Immune System & Kidney Support Lower risk of sepsis and other infections, possibly due to reduced oxidative stress and improved immune response
Generally, GLP-1 agonist medications are FDA approved for adults aged 18 years and older with certain body mass indexes (BMI) (typically a BMI of 30 or above, or a BMI of 27 or above if you have a weight-related health condition such as hypertension, high cholesterol, weight-related anxiety, liver disease, sleep apnea or PCOS)
The Cardiovascular Biology of Glucagon-Like Peptide-1
These chemicals, often referred to as forever chemicals, persist in the environment and pose significant health risks, including liver changes, increased cholesterol, and heightened risks of kidney and testicular cancer
Note: These must be justified with pharmacokinetic data or prior knowledge